Management of branch-duct intraductal papillary mucinous neoplasms of the pancreas: Observation with MR imaging

Sang Soo Shin, Diane M. Armao, Monty Shah, Young Hoon Kim, Chang-Hee Lee, Tara Rubinas, Lauren M. Brubaker, Richard C. Semelka

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Purpose: To evaluate the clinical outcomes of conservative management by observation with MRI of patients with branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs). Materials and Methods: Twenty-three consecutive patients, who were followed up by MRI with magnetic resonance cholangiopancreatography (MRCP) over a period of more than 9 months after initial MRI examinations, were enrolled in this study. On MRI, number of lesions, the maximum diameter of BD-IPMNs, lesion location, the presence of associated dilatation of main pancreatic duct (MPD), the presence of enhancing mural nodules within the lesion and the presence of interval change were retrospectively reviewed on initial and follow-up MR images in consensus by two radiologists. All patients were evaluated to search for evidence of malignant progression of disease. Results: The follow-up period ranged from 10 to 96 months (mean, 37 months). On initial MRI with MRCP, a total of 39 lesions were found in 23 patients. The maximum diameter of BD-IPMNs ranged between 6 and 32 mm, with a mean of 12 mm. Thirty-four lesions (87%) of 19 patients remained unchanged in the maximum diameter. Five lesions (13%) of four patients showed an increase in the maximum diameter. Enhancing mural nodules were not found in any individual, neither on the initial MRI study nor on the follow-up studies. There was no patient who had evidence of local aggressive growth of tumor or evidence of metastases to distant sites. Conclusion: Our study suggests that branch-duct IPMNs without enhancing mural nodules are essentially benign and should be managed nonoperatively through observation by MRI.

Original languageEnglish
Pages (from-to)1440-1446
Number of pages7
JournalMagnetic Resonance Imaging
Volume28
Issue number10
DOIs
Publication statusPublished - 2010 Dec 1
Externally publishedYes

Fingerprint

Pancreatic Neoplasms
Magnetic resonance imaging
Ducts
Observation
Imaging techniques
Magnetic Resonance Cholangiopancreatography
Magnetic resonance
Neoplasms
Pancreatic Ducts
Disease Progression
Tumors
Dilatation
Neoplasm Metastasis
Growth

Keywords

  • Branch duct type
  • Intraductal papillary mucinous neoplasms
  • Magnetic resonance (MR)
  • Outcome
  • Pancreas

ASJC Scopus subject areas

  • Biophysics
  • Biomedical Engineering
  • Radiology Nuclear Medicine and imaging

Cite this

Management of branch-duct intraductal papillary mucinous neoplasms of the pancreas : Observation with MR imaging. / Shin, Sang Soo; Armao, Diane M.; Shah, Monty; Kim, Young Hoon; Lee, Chang-Hee; Rubinas, Tara; Brubaker, Lauren M.; Semelka, Richard C.

In: Magnetic Resonance Imaging, Vol. 28, No. 10, 01.12.2010, p. 1440-1446.

Research output: Contribution to journalArticle

Shin, Sang Soo ; Armao, Diane M. ; Shah, Monty ; Kim, Young Hoon ; Lee, Chang-Hee ; Rubinas, Tara ; Brubaker, Lauren M. ; Semelka, Richard C. / Management of branch-duct intraductal papillary mucinous neoplasms of the pancreas : Observation with MR imaging. In: Magnetic Resonance Imaging. 2010 ; Vol. 28, No. 10. pp. 1440-1446.
@article{9f81b2bdf3914134a45986609b1a1032,
title = "Management of branch-duct intraductal papillary mucinous neoplasms of the pancreas: Observation with MR imaging",
abstract = "Purpose: To evaluate the clinical outcomes of conservative management by observation with MRI of patients with branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs). Materials and Methods: Twenty-three consecutive patients, who were followed up by MRI with magnetic resonance cholangiopancreatography (MRCP) over a period of more than 9 months after initial MRI examinations, were enrolled in this study. On MRI, number of lesions, the maximum diameter of BD-IPMNs, lesion location, the presence of associated dilatation of main pancreatic duct (MPD), the presence of enhancing mural nodules within the lesion and the presence of interval change were retrospectively reviewed on initial and follow-up MR images in consensus by two radiologists. All patients were evaluated to search for evidence of malignant progression of disease. Results: The follow-up period ranged from 10 to 96 months (mean, 37 months). On initial MRI with MRCP, a total of 39 lesions were found in 23 patients. The maximum diameter of BD-IPMNs ranged between 6 and 32 mm, with a mean of 12 mm. Thirty-four lesions (87{\%}) of 19 patients remained unchanged in the maximum diameter. Five lesions (13{\%}) of four patients showed an increase in the maximum diameter. Enhancing mural nodules were not found in any individual, neither on the initial MRI study nor on the follow-up studies. There was no patient who had evidence of local aggressive growth of tumor or evidence of metastases to distant sites. Conclusion: Our study suggests that branch-duct IPMNs without enhancing mural nodules are essentially benign and should be managed nonoperatively through observation by MRI.",
keywords = "Branch duct type, Intraductal papillary mucinous neoplasms, Magnetic resonance (MR), Outcome, Pancreas",
author = "Shin, {Sang Soo} and Armao, {Diane M.} and Monty Shah and Kim, {Young Hoon} and Chang-Hee Lee and Tara Rubinas and Brubaker, {Lauren M.} and Semelka, {Richard C.}",
year = "2010",
month = "12",
day = "1",
doi = "10.1016/j.mri.2010.06.026",
language = "English",
volume = "28",
pages = "1440--1446",
journal = "Magnetic Resonance Imaging",
issn = "0730-725X",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - Management of branch-duct intraductal papillary mucinous neoplasms of the pancreas

T2 - Observation with MR imaging

AU - Shin, Sang Soo

AU - Armao, Diane M.

AU - Shah, Monty

AU - Kim, Young Hoon

AU - Lee, Chang-Hee

AU - Rubinas, Tara

AU - Brubaker, Lauren M.

AU - Semelka, Richard C.

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Purpose: To evaluate the clinical outcomes of conservative management by observation with MRI of patients with branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs). Materials and Methods: Twenty-three consecutive patients, who were followed up by MRI with magnetic resonance cholangiopancreatography (MRCP) over a period of more than 9 months after initial MRI examinations, were enrolled in this study. On MRI, number of lesions, the maximum diameter of BD-IPMNs, lesion location, the presence of associated dilatation of main pancreatic duct (MPD), the presence of enhancing mural nodules within the lesion and the presence of interval change were retrospectively reviewed on initial and follow-up MR images in consensus by two radiologists. All patients were evaluated to search for evidence of malignant progression of disease. Results: The follow-up period ranged from 10 to 96 months (mean, 37 months). On initial MRI with MRCP, a total of 39 lesions were found in 23 patients. The maximum diameter of BD-IPMNs ranged between 6 and 32 mm, with a mean of 12 mm. Thirty-four lesions (87%) of 19 patients remained unchanged in the maximum diameter. Five lesions (13%) of four patients showed an increase in the maximum diameter. Enhancing mural nodules were not found in any individual, neither on the initial MRI study nor on the follow-up studies. There was no patient who had evidence of local aggressive growth of tumor or evidence of metastases to distant sites. Conclusion: Our study suggests that branch-duct IPMNs without enhancing mural nodules are essentially benign and should be managed nonoperatively through observation by MRI.

AB - Purpose: To evaluate the clinical outcomes of conservative management by observation with MRI of patients with branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs). Materials and Methods: Twenty-three consecutive patients, who were followed up by MRI with magnetic resonance cholangiopancreatography (MRCP) over a period of more than 9 months after initial MRI examinations, were enrolled in this study. On MRI, number of lesions, the maximum diameter of BD-IPMNs, lesion location, the presence of associated dilatation of main pancreatic duct (MPD), the presence of enhancing mural nodules within the lesion and the presence of interval change were retrospectively reviewed on initial and follow-up MR images in consensus by two radiologists. All patients were evaluated to search for evidence of malignant progression of disease. Results: The follow-up period ranged from 10 to 96 months (mean, 37 months). On initial MRI with MRCP, a total of 39 lesions were found in 23 patients. The maximum diameter of BD-IPMNs ranged between 6 and 32 mm, with a mean of 12 mm. Thirty-four lesions (87%) of 19 patients remained unchanged in the maximum diameter. Five lesions (13%) of four patients showed an increase in the maximum diameter. Enhancing mural nodules were not found in any individual, neither on the initial MRI study nor on the follow-up studies. There was no patient who had evidence of local aggressive growth of tumor or evidence of metastases to distant sites. Conclusion: Our study suggests that branch-duct IPMNs without enhancing mural nodules are essentially benign and should be managed nonoperatively through observation by MRI.

KW - Branch duct type

KW - Intraductal papillary mucinous neoplasms

KW - Magnetic resonance (MR)

KW - Outcome

KW - Pancreas

UR - http://www.scopus.com/inward/record.url?scp=78449258388&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78449258388&partnerID=8YFLogxK

U2 - 10.1016/j.mri.2010.06.026

DO - 10.1016/j.mri.2010.06.026

M3 - Article

C2 - 20833500

AN - SCOPUS:78449258388

VL - 28

SP - 1440

EP - 1446

JO - Magnetic Resonance Imaging

JF - Magnetic Resonance Imaging

SN - 0730-725X

IS - 10

ER -